Schrödinger's SGR-1505 Phase 1 data shows encouraging safety and niche efficacy, especially in BTKi-resistant Waldenström macroglobulinemia patients. Despite a headline 22% ORR, the nuanced data ...
Why You Can’t Just Use a Spectrum Analyzer Industry has an increasing demand for spectrally pure signals in applications such as imaging radar, mobile communications, satellite communications, weather ...
Obefazimod’s strong Phase 3 induction data positions Abivax as a leading UC contender, with a novel mechanism and favorable safety profile. The ABTECT program’s robust design and inclusion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback